Announcements Trials
Browse Landscape

Status

Recruiting 18Completed 13Active not recruiting 5Withdrawn 3Terminated 3Not yet recruiting 3Unknown 2Suspended 1No longer available 1Approved for marketing 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 2Infections 1

Interventions

Cytarabine 55Decitabine 33Azacitidine 30Idarubicin 22venetoclax 21fludarabine 16Cyclophosphamide 16Granulocyte Colony-Stimulating Factor 15Daunorubicin 12Mitoxantrone 9Etoposide 8Cladribine 8Busulfan 8Aclarubicin 8Homoharringtonine 7Filgrastim 7Peripheral Blood Stem Cell Transplantation 6fludarabine phosphate 5aclacinomycins 4Tretinoin 4Sorafenib 4Radiotherapy 4Polymerase Chain Reaction 4Mycophenolic Acid 4Lenalidomide 4Gemtuzumab 4Cyclosporine 4Clofarabine 4Arsenic Trioxide 4sargramostim 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Leukemia, Myeloid, Acute × gilteritinib × Clear all
NCT05791890 2023-03-30

GilteRInf

University of Rome Tor Vergata

Unknown
78 enrolled
Other hematologic neoplasm

Infections, Leukemia, Myeloid, Acute

NCT05312112 2023-03-02

Real World Outcomes Using Novel Agents for AML in the UK

Guy's and St Thomas' NHS Foundation Trust

Unknown
1,000 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡